$RCPT Recent News U.S. benchmarks teeter on ma
Post# of 72711
U.S. benchmarks teeter on major support 11:46 a.m. Sept. 30, 2014 - Michael Ashbaugh
U.S. benchmarks teeter on major support 11:22 a.m. Sept. 30, 2014 - Michael Ashbaugh
Nasdaq Composite violates first support 12:38 p.m. Sept. 15, 2014 - Michael Ashbaugh
RadioShack dives on results; Tyson extends drop 3:36 p.m. June 10, 2014 - Sue Chang
Pep Boys shares rise after earnings results 5:49 p.m. June 9, 2014 - Wallace Witkowski
Receptos shares surge 40% on MS drug study result 4:46 p.m. June 9, 2014 - Wallace Witkowski
Receptos (RCPT) Hits New Lifetime High 37 min ago - TheStreet.com
Receptos lead product successful in Phase 2 for UC at higher dose 6:25 p.m. Oct. 27, 2014 - Seeking Alpha
Receptos Reports Promising Results for Ulcerative Colitis Drug 5:30 p.m. Oct. 27, 2014 - The Wall Street Journal Interactive Edition
Surprising Stocks That Performed Best for Billionaires in 2014 8:48 a.m. Oct. 27, 2014 - TheStreet.com
EC approves ulcerative colitis med 11:31 a.m. Oct. 22, 2014 - Seeking Alpha
Forward Pharma on deck for IPO 8:33 a.m. Oct. 7, 2014 - Seeking Alpha
Receptos (RCPT) Reaches New Lifetime High Today 10:17 a.m. Sept. 29, 2014 - TheStreet.com
Multiple Sclerosis Drugs Could Transform Market Again 5:07 p.m. Sept. 26, 2014 - Investors Business Daily
InsiderInsights.com Daily Round Up 9/24/14: Mercer International, OPKO Health, New Media, CTI BioPharma 8:17 a.m. Sept. 25, 2014 - Seeking Alpha
InsiderInsights.com Daily Round Up 9/20/14: OPK, RSG, VHC, GMAN 6:06 a.m. Sept. 22, 2014 - Seeking Alpha
UPDATE: Credit Suisse Reiterates On Receptos Inc Ahead Of Investor Call 7:19 a.m. Sept. 15, 2014 - benzinga.com
Trade-Ideas: Receptos (RCPT) Is Today's New Lifetime High Stock 9:49 a.m. Sept. 11, 2014 - TheStreet.com
Fraud Allegations Cause 21Vianet Group To Plunge 1:24 p.m. Sept. 10, 2014 - TheStreet.com
Receptos MS Drug Yields More Good Data; Stock Jumps 10:58 a.m. Sept. 10, 2014 - Investors Business Daily
Today's Dead Cat Bounce Stock: Receptos (RCPT) 9:58 a.m. Sept. 10, 2014 - TheStreet.com
4 Biotechs That Might Be Bought Soon 10:53 a.m. Aug. 29, 2014 - Investors Business Daily
Receptos Up 8%; Wedbush Sees Possible Takeover 3:43 p.m. Aug. 25, 2014 - benzinga.com
InsiderInsights.com Daily Round Up: 8/15/14 3:06 a.m. Aug. 17, 2014 - Seeking Alpha
Receptos (RCPT) Shares March Higher, Can It Continue? - Tale of the Tape 9:57 a.m. Aug. 15, 2014 - Zacks.com
Receptos Inc Stock Upgraded (RCPT) 11:11 a.m. Aug. 14, 2014 - TheStreet.com
Receptos Reports Positive Phase 2 Results for TOUCHSTONE Trial of RPC1063 in Ulcerative Colitis 4:02 p.m. Oct. 27, 2014 - GlobeNewswire
Receptos Announces First Patient Treated With Anti-Interleukin-13 Antibody in Phase 2 Trial for Eosinophilic Esophagitis 8:01 a.m. Oct. 3, 2014 - GlobeNewswire
Critical Alerts For FuelCell Energy, Receptos Inc., HD Supply Holdings Inc., Westport Innovations and Organovo Released By InvestorsObserver 9:31 a.m. Sept. 11, 2014 - PR Newswire - PRF
Receptos Announces Oral Podium Presentation at MS Boston 2014 8:02 a.m. Sept. 10, 2014 - GlobeNewswire
Flagship Ventures Appoints Agricultural Industry Leader Robert Berendes as Venture Partner 9:00 a.m. Aug. 25, 2014 - PR Newswire - PRF
Receptos to Present at Wedbush PacGrow Life Sciences Conference 8:01 a.m. Aug. 8, 2014 - GlobeNewswire
Receptos to Hold Second Quarter 2014 Financial Results Conference Call and Webcast 4:04 p.m. Aug. 7, 2014 - GlobeNewswire
Receptos Announces Appointment of Mary Szela and Richard Heyman, Ph.D. to Board of Directors 8:07 a.m. July 29, 2014 - GlobeNewswire
Flagship Ventures Adds Pharma Industry Veteran Roger J. Pomerantz, M.D., F.A.C.P. as Senior Partner 9:00 a.m. July 14, 2014 - PR Newswire - PRF
Clinical Trial Update, Recommendations for Approval, Share Repurchase Programs, and Closing of Public Offering - Analyst Notes on Medtronic, Regeneron, Lilly, United Therapeutics and Receptos 5:50 a.m. July 2, 2014 - PR Newswire - PRF
Receptos Announces Closing of Underwritten Public Offering of Common Stock 9:35 a.m. June 24, 2014 - GlobeNewswire
Receptos Announces Pricing of Underwritten Public Offering of Common Stock 7:44 p.m. June 18, 2014 - GlobeNewswire
Receptos Announces Proposed Underwritten Public Offering of Common Stock 4:09 p.m. June 17, 2014 - GlobeNewswire
Technical Update, Leadership Appointments, and Clinical Trial Results - Analyst Notes on Achillion, Nektar, CytRx, Galena and Receptos 5:20 a.m. June 12, 2014 - PR Newswire - PRF
Receptos Reports Positive Phase 2 Results for RPC1063 in Relapsing Multiple Sclerosis 4:06 p.m. June 9, 2014 - GlobeNewswire
Flagship Ventures Commences Its Sixth VentureLabs™ Fellowship Program Focused On Entrepreneurial Innovation 9:00 a.m. June 5, 2014 - PR Newswire - PRF
Receptos Reports First Quarter 2014 Financial Results 8:02 a.m. May 12, 2014 - GlobeNewswire
Receptos to Hold First Quarter 2014 Financial Results Conference Call and Webcast 8:01 a.m. May 7, 2014 - GlobeNewswire
Receptos to Present at Bank of America Merrill Lynch 2014 Health Care Conference 8:02 a.m. May 6, 2014 - GlobeNewswire
Receptos to Present at Deutsche Bank Securities Annual Healthcare Conference 8:02 a.m. May 1, 2014 - GlobeNewswire